Graf Akcie FPRX (Five Prime Therapeutics Inc). Diskuze k akciím FPRX. Aktuální informace FPRX.

Základní informace o společnosti Five Prime Therapeutics Inc (Akcie FPRX)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 1.77B
Hodnota podniku (EV) N/A
Tržby N/A
EBITDA N/A
Zisk -84.33
Růst v tržbách Q/Q -122.06 %
Růst v tržbách Y/Y -11.40 %
P/E (Cena vůči ziskům) 0.00
Forward P/E N/A
EV/Sales 49.05
EV/EBITDA N/A
EV/EBIT N/A
PEG 0.03
Price/Sales 134.29
P/FCF N/A
Price/Book 6.68
Účetní hodnota na akcii 7.34
Hotovost na akcii 8.00
FCF vůči ceně -3.28 %
Počet zaměstnanců 0
Tržba na zaměstnance N/A
Profit margin -639.92 %
Operating margin -704.74 %
Gross margin 100.00 %
EBIT margin -690.23 %
EBITDA margin -746.72 %
EPS - Zisk na akcii N/A
EPS - Kvartální růst -42.70 %
EPS - Očekávaný růst příští rok -12.28 %
Return on assets -38.32 %
Return on equity -54.86 %
ROIC -32.73 %
ROCE -29.39 %
Dluhy/Equity 0.25
Čistý dluh/EBITDA 2.74
Current ratio 13.18
Quick Ratio 13.18
Volatilita 0.91
Beta 0.00
RSI 92.58
Cílová cena analytiků 27
Známka akcie (dle analytiků) 1.25
Insider ownership 3.19 %
Institutional ownership 47.10 %
Počet akcií 46.572M
Procento shortovaných akcií 7.57 %
Short ratio 3.24 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 2013
Země United States

Finanční výsledky akcie FPRX

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$14.874$49.868$39.508$30.691$379.801$19.231
Cost Of Goods Sold------
Gross Profit$14.874$49.868$39.508$30.691$379.801$19.231
Research And Development Expenses$114.063$156.352$150.908$94.072$70.197$43.173
SG&A Expenses$42.749$39.671$40.002$35.831$22.631$13.632
Other Operating Income Or Expenses------
Operating Expenses$156.812$196.023$190.91$129.903$92.828$56.805
Operating Income$-141.938$-146.155$-151.402$-99.212$286.973$-37.574
Total Non-Operating Income/Expense$4.736$5.708$2.884$2.467$0.484$0.15
Pre-Tax Income$-137.202$-140.447$-148.518$-96.745$287.457$-37.424
Income Taxes--$1.704$-31.048$37.81-
Income After Taxes$-137.202$-140.447$-150.222$-65.697$249.647$-37.424
Other Income------
Income From Continuous Operations$-137.202$-140.447$-150.222$-65.697$249.647$-37.424
Income From Discontinued Operations------
Net Income$-137.202$-140.447$-150.222$-65.697$249.647$-37.424
EBITDA$-138.788$-142.885$-147.268$-93.283$290.676$-34.531
EBIT$-141.938$-146.155$-151.402$-99.212$286.973$-37.574
Basic Shares Outstanding353428272621
Shares Outstanding353428272721
Basic EPS$-3.92$-4.13$-5.38$-2.44$9.73$-1.79
EPS - Earnings Per Share$-3.92$-4.13$-5.38$-2.44$9.23$-1.79
# 2020 2019 2018 2017 2016 2015
Current Ratio7.241110.49836.10411.36076.65617.6335
Long-term Debt / Capital------
Debt/Equity Ratio------
Gross Margin100100100100100100
Operating Margin-954.2693-293.0838-383.2186-323.260975.5588-195.3824
EBIT Margin-954.2693-293.0838-383.2186-323.260975.5588-195.3824
EBITDA Margin-933.0914-286.5264-372.7549-303.942576.5338-179.559
Pre-Tax Profit Margin-922.4284-281.6375-375.9188-315.222775.6862-194.6024
Net Profit Margin-922.4284-281.6375-380.2319-214.059565.731-194.6024
Asset Turnover0.06640.15510.11480.06850.69270.1236
Inventory Turnover Ratio------
Receiveable Turnover3.63059.78573.00833.556793.685546.9049
Days Sales In Receivables100.538237.2993121.331102.62243.8967.7817
ROE - Return On Equity-91.1805-52.9711-56.6444-16.777657.6278-43.9223
Return On Tangible Equity-91.1805-52.9711-56.6444-16.777657.6278-43.9223
ROA - Return On Assets-61.2121-43.6803-43.6632-14.655345.5323-24.0466
ROI - Return On Investment-91.1805-52.9711-56.6444-16.777657.6278-43.9223
Book Value Per Share4.27247.6319.411314.234416.58713.9301
Operating Cash Flow Per Share0.34980.4086-1.0558-13.65229.96195.3179
Free Cash Flow Per Share0.63250.2514-1.1223-13.67229.95085.3853

Porovnání s konkurencí: Akcie FPRX

Společnost P/E PEG Růst v tržbách (roční) Růst v EPS Return on equity P/B Profit margin
FPRX 0.00 0.03 -11.40 % -12.28 % -54.86 % 6.68 -639.92 %
Akcie BMY N/A 14.08 27.31 % 19.02 % -12.51 % 3.43 -21.20 %
Akcie GSK 16.60 3.36 N/A % -14.00 % 29.69 % 4.85 16.86 %
Akcie JNJ 23.93 1.67 10.79 % 7.27 % 27.01 % 6.67 17.82 %
Akcie LLY 35.62 1.63 16.46 % 27.92 % 101.98 % 39.72 25.24 %
Akcie LXRX 13.39 N/A -97.79 % -122.54 % 28.54 % 5.65 -244.11 %
Akcie PFE 17.66 1.97 4.96 % 50.00 % 19.81 % 3.72 22.95 %
Akcie REGN 9.43 1.06 54.84 % 7.66 % 51.44 % 5.45 41.35 %
Akcie XNCR 96.18 N/A 152.48 % 172.73 % 3.97 % 3.95 -56.51 %

Nedávné obchody insiderů: Akcie FPRX

Jméno Obchod Cena Objem
Partners L P/Ilbiotechnolog...
Nákup
22 Sep 2020
$3.80 $122
Partners L P/Ilbiotechnolog...
Nákup
6 Oct 2020
$5.04 $1,740,015
Partners L P/Ilbiotechnolog...
Nákup
4 Nov 2020
$4.89 $2,183,688
Partners L P/Ilbiotechnolog...
Prodej
11 Nov 2020
$20.19 $149,271,535
William R Ringo
Director
Option
11 Nov 2020
$2.41 $190,291
Helen Louise Collins
EVP and Chief Medical Officer
Option
11 Nov 2020
$18.00 $396,000
David V Smith
Executive Vice President and CFO
Option
11 Nov 2020
$18.00 $396,000
Francis Willard Sarena
Chief Strategy Officer
Option
11 Nov 2020
$18.00 $396,000
Helen Louise Collins
EVP and Chief Medical Officer
Option
11 Dec 2020
$16.14 $355,080
David V Smith
Executive Vice President and CFO
Option
11 Dec 2020
$16.14 $355,080
Francis Willard Sarena
Chief Strategy Officer
Option
11 Dec 2020
$16.14 $355,080

Diskuze k akciím FPRX